Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JONATHAN G OWNBY

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1780887877
CMS profile
35246
Location
ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$87,820.66

259 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 6; records 101–150 of 259 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JONATHAN G OWNBY

NPI 1780887877 · CMS profile ID 35246

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 6; records 101–150 of 259 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1780887877?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JONATHAN G OWNBY, NPI 1780887877, CMS profile ID 35246. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 259 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1780887877?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JONATHAN G OWNBY, NPI 1780887877, CMS profile ID 35246. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 259 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1780887877?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JONATHAN G OWNBY, NPI 1780887877, CMS profile ID 35246, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 6; records 101–150 of 259 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1780887877?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

259 matching records · $87,820.66 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 259 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 259.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $20.6008/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135071117 CMS
Xeris Pharmaceuticals, Inc. $22.6808/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144599672 CMS
Amneal Pharmaceuticals LLC $22.1108/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139197284 CMS
Alexion Pharmaceuticals, Inc. $16.5508/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093905042 CMS
Abbott Laboratories $16.0708/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125271684 CMS
BETA BIONICS, INC. $13.9908/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087881065 CMS
BETA BIONICS, INC. $67.3508/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087881105 CMS
Embecta Corp. $20.4108/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144992007 CMS
Corcept Therapeutics $600.0008/01/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738430 CMS
Averitas Pharma Inc. $26.8207/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133440007 CMS
Corcept Therapeutics $1,200.0007/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738488 CMS
Astellas Pharma US Inc $14.9607/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139373309 CMS
Lilly USA, LLC $7.0107/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135091859 CMS
Corcept Therapeutics $23.6607/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738434 CMS
Lilly USA, LLC $21.0207/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135072563 CMS
AstraZeneca Pharmaceuticals LP $18.1907/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104751352 CMS
Lilly USA, LLC $17.9507/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135071109 CMS
Abbott Laboratories $71.0807/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125271668 CMS
Abbott Laboratories $15.2007/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125271670 CMS
Amgen Inc. $14.1007/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111667520 CMS
Corcept Therapeutics $3,680.0007/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738478 CMS
Dexcom, Inc. $18.9307/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153310365 CMS
Embecta Corp. $19.1807/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144991993 CMS
Lilly USA, LLC $18.6207/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135061729 CMS
Corcept Therapeutics $1,200.0007/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738458 CMS
Verity Pharmaceuticals Inc. $20.6807/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080603904 CMS
Corcept Therapeutics $25.0206/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738410 CMS
Amneal Pharmaceuticals LLC $23.1706/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139197282 CMS
Corcept Therapeutics $183.3306/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738398 CMS
Novo Nordisk Inc $7.1706/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097109512 CMS
SANOFI-AVENTIS U.S. LLC $31.0006/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139802164 CMS
Novo Nordisk Inc $17.4406/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096950131 CMS
Corcept Therapeutics $1,200.0006/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738456 CMS
Corcept Therapeutics $1,200.0006/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738460 CMS
Corcept Therapeutics $1,200.0006/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738462 CMS
Lilly USA, LLC $16.7406/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135085798 CMS
Novartis Pharmaceuticals Corporation $15.1306/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087283741 CMS
Corcept Therapeutics $7.1406/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117738408 CMS
Lilly USA, LLC $16.0006/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135071113 CMS
Dexcom, Inc. $18.9406/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153310363 CMS
Embecta Corp. $19.9306/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144992817 CMS
Radius Health, Inc. $21.9006/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089962332 CMS
Xeris Pharmaceuticals, Inc. $21.4706/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144599692 CMS
Amgen Inc. $17.2706/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111667518 CMS
Esperion Therapeutics, Inc. $18.6005/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1129449454 CMS
Lilly USA, LLC $21.0205/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135071115 CMS
Novo Nordisk Inc $6.6705/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097770097 CMS
Lilly USA, LLC $16.7405/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135072561 CMS
Amneal Pharmaceuticals LLC $23.1605/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139197280 CMS
SANOFI-AVENTIS U.S. LLC $31.9505/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139802134 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $49,835.82 277
PY2020 $14,897.97 204
PY2021 $33,471.05 229
PY2022 $18,130.35 254
PY2023 $28,729.59 248
PY2024 $87,820.66 259
PY2025 $58,396.40 199

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $140,241.20 23
PY2024 Principal investigator $61,698.60 9
PY2023 Recipient $2,404.56 10
PY2023 Principal investigator $2,400.00 4
PY2022 Principal investigator $2,100.00 7
PY2021 Recipient $1,651.61 11
PY2021 Principal investigator $27,867.86 23
PY2020 Principal investigator $27,989.20 23
PY2019 Principal investigator $11,237.90 7

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

23 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,587.00 12/31/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES
A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism No dispute reported 06/30/2026 1202535033
Principal investigator 1 ABBVIE INC. $1,200.00 12/30/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202532230
Principal investigator 1 ABBVIE INC. $3,723.70 12/09/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202529762
Principal investigator 1 ABBVIE INC. $5,569.20 12/05/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202529446
Principal investigator 1 Chiesi USA, Inc. $150.00 12/01/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES
MEASuRE: Metreleptin Effectiveness And Safety Registry (MEASuRE) No dispute reported 06/30/2026 1234408317
Principal investigator 1 Chiesi USA, Inc. $150.00 12/01/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES
MEASuRE: Metreleptin Effectiveness And Safety Registry (MEASuRE) No dispute reported 06/30/2026 1234408322
Principal investigator 1 Chiesi USA, Inc. $150.00 12/01/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES
MEASuRE: Metreleptin Effectiveness And Safety Registry (MEASuRE) No dispute reported 06/30/2026 1234408325
Principal investigator 1 Chiesi USA, Inc. $450.00 11/20/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES
MEASuRE: Metreleptin Effectiveness And Safety Registry (MEASuRE) No dispute reported 06/30/2026 1234408048
Principal investigator 1 Chiesi USA, Inc. $450.00 11/20/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES
MEASuRE: Metreleptin Effectiveness And Safety Registry (MEASuRE) No dispute reported 06/30/2026 1234408053
Principal investigator 1 Chiesi USA, Inc. $450.00 11/20/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES
MEASuRE: Metreleptin Effectiveness And Safety Registry (MEASuRE) No dispute reported 06/30/2026 1234408056
Principal investigator 1 ABBVIE INC. $17,451.20 11/05/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202522071
Principal investigator 1 ABBVIE INC. $7,114.90 10/09/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202515721
Principal investigator 1 ABBVIE INC. $21,668.40 09/04/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202508796
Principal investigator 1 ABBVIE INC. $10,666.50 08/06/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202502881
Principal investigator 1 ABBVIE INC. $2,432.50 07/15/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202498302
Principal investigator 1 ABBVIE INC. $1,672.00 07/11/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202498092
Principal investigator 1 ABBVIE INC. $5,645.90 07/02/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202496569
Principal investigator 1 ABBVIE INC. $16,836.30 06/03/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202487825
Principal investigator 1 ABBVIE INC. $14,027.00 05/07/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202482629
Principal investigator 1 ABBVIE INC. $5,046.60 04/03/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202473356
Principal investigator 1 ABBVIE INC. $8,840.00 03/07/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202459658
Principal investigator 1 ABBVIE INC. $10,660.00 02/06/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES PC
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202448247
Principal investigator 1 Chiesi USA, Inc. $300.00 01/08/2025 Non-covered Recipient Entity
ATLANTA DIABETES ASSOCIATES
MEASuRE: Metreleptin Effectiveness And Safety Registry (MEASuRE) No dispute reported 06/30/2026 1234394513